Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 12.0B | -13.1B | 24.1B | 1.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 347M | -29.8B | 30.8B | 357M |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 54M | 107M | -16M | 128M |
| Other income expense | 55M | -90M | -452M | 493M |
| Pretax income | 1.2B | 1.2B | 582M | 1.8B |
| Tax provision | 344M | 501M | 209M | 363M |
| Net income | 875M | 678M | 899M | 875M |
| Basic EPS | 2.3 | — | — | — |
| Diluted EPS | 2.3 | — | — | — |
| Basic average shares | 258.2M | — | — | — |
| Diluted average shares | 258.2M | — | — | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -272M | -293M | -397M | -357M |
| Preferred stock dividends | — | — | — | — |